TRACY HAMMOND: Open Payments
NPI 1093200339 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 19 payments from 9 companies in 2025. Trend: 2023 $328 · 2024 $285 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 3 | $69 |
| Astellas Pharma US Inc | 2 | $58 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $56 |
| MILLICENT US INC | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Organon LLC | 2 | $26 |
| CooperSurgical, Inc. | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: ZURZUVAE, Veozah, Auvelity, FEMLYV, NEXPLANON, Paragard T 380A, ACCRUFER, INTRAROSA.
Industry payments across IN — which companies pay providers there.
